Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Mid-Cap · Goldman Sachs

GMVAX Performance & Returns History

Ticker GMVAX · Since 2014-01-31 · · Holdings as of May 31, 2026

Expense ratio
1.17%$117/yr per $10k
5-yr return
+6.6%annualized
1-yr return
+4.7%as of Dec 2024
Net assets
$151.8Mall share classes
Holdings
98

Bottom line

How has GMVAX performed?

As of Dec 31, 2024, GMVAX returned +4.7% over the past year, +6.6% a year over five years, +6.6% a year over ten years. That means $10,000 invested ten years earlier would have grown to about $18,900. Its five-year return beat 34% of mid-cap funds we track.

Updated Dec 31, 2024

Trailing returns vs benchmark and category

1 yr5 yr10 yrSince inception
GMVAX+4.7%+6.6%+6.6%—
Mid-Cap median+7.9%+8.1%+9.9%—

Source: Prospectus as of Dec 31, 2024; category medians computed by MutualFund.com

Recent monthly returns

For the three months ending May 31, 2026, GMVAX returned −5.30%, +9.83%, +3.20% (oldest to newest), per SEC Form N-PORT.

Past performance does not guarantee future results. Returns assume reinvested distributions and are net of fund expenses, as reported by the fund.